Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Antigenic and Topographical Imprinting of Human B Cell Memory and Its Reprogramming Potential

Project description

Reprogramming mucosal memory B cells

Mucosal immunity protects barrier surfaces such as the nose, throat and lungs against pathogens. Unlike systemic immunity, these local responses can be short-lived. The aftermath of COVID-19 vaccines demonstrated that despite the presence of serum antibodies, upper-airway protection was rapidly lost. The ERC-funded TopBMemory project aims to investigate how the site of first antigen exposure shapes immune memory and how later exposures through different routes modify memory of B cells. Using single-cell multiomics and organoid models, researchers aim to map memory B cell plasticity. The goal is to guide next-generation vaccines that strengthen durable mucosal immunity.

Objective

The novel COVID-19 vaccines have effectively reduced morbidity and mortality but unexpectedly failed to provide long-lasting sterilizing immunity. While specific serum antibody (Ab) titers were durable, local upper respiratory tract (URT) mucosal Ab responses were surprisingly short-lived. This shows both our lack of and need for a deeper understanding of URT mucosal immunity and its distinctions from systemic immunity. My proposal is designed to answer two key questions arising from this: How does the initial exposure site—mucosal or systemic—shape and imprint immune memory? And how is this imprinting reprogrammed by subsequent exposures via different exposure routes?
In the TopBMemory project, I will: (1) delineate how the antigen (ag) nature and primary exposure site shape human memory B cell (MBC) subset heterogeneity and their imprinting. I will generate the first single-cell (sc) multiomic profiles of ag-specific (ag+) MBCs with context-specific imprints by a project-specific pipeline integrating transcriptomic, epigenomic, and phenotypic data. (2) Determine how alternative re-exposure sites reprogram existing imprints—overwrite or complement them—which will be the first demonstration of the potential for natural imprint reprogramming in MBC. (3) Test targeted reprogramming of MBC subsets within tonsil and nasal mucosa-derived organoid co-culture systems. My findings will significantly advance understanding of MBC ontogeny and plasticity, both in host protection and also immunopathologies, and inform the development of a new generation of vaccines and therapies.
The groundbreaking nature of TopBMemory lies in its first large-scale contextualization of human ag+ MBC subset origins and functions, exploring their responses and adaptions to varying routes of ag re-exposure. This is complemented by the development of innovative toolkits for sc multiomics and MBC (re-)programming within advanced organoid systems, to explore and guide precise manipulation strategies.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-STG

See all projects funded under this call

Host institution

CHARITE - UNIVERSITAETSMEDIZIN BERLIN
Net EU contribution
€ 1 499 963,00
Address
Chariteplatz 1
10117 Berlin
Germany
Region
Berlin Berlin Berlin
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 499 963,00

Beneficiaries (1)